Logo image of CPTA

Capitala Finance Crp (CPTA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CPTA -

25.4
+0.85 (+3.46%)
Last: 7/1/2021, 8:00:00 PM
Fundamental Rating

2

Overall CPTA gets a fundamental rating of 2 out of 10. We evaluated CPTA against 238 industry peers in the Capital Markets industry. Both the profitability and financial health of CPTA have multiple concerns. CPTA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CPTA has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA 6.05%
ROE 15.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -2.29%
PM (TTM) 79.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

  • There is no outstanding debt for CPTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • Based on the Altman-Z score of 0.08, we must say that CPTA is in the distress zone and has some risk of bankruptcy.
  • CPTA has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Altman-Z 0.08
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • A Current Ratio of 14.72 indicates that CPTA has no problem at all paying its short term obligations.
  • A Quick Ratio of 14.72 indicates that CPTA has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 14.72
Quick Ratio 14.72

More info and screens

2

3. Growth

3.1 Past

  • The earnings per share for CPTA have decreased strongly by -103.33% in the last year.
  • Measured over the past years, CPTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -57.96% on average per year.
  • The Revenue for CPTA has decreased by -36.77% in the past year. This is quite bad
  • Measured over the past years, CPTA shows a very negative growth in Revenue. The Revenue has been decreasing by -16.20% on average per year.
EPS 1Y (TTM)-103.33%
EPS 3Y-73.39%
EPS 5Y-57.96%
EPS Q2Q%125.7%
Revenue 1Y (TTM)-36.77%
Revenue growth 3Y-19.71%
Revenue growth 5Y-16.2%
Sales Q2Q%-30.36%

3.2 Future

  • Based on estimates for the next years, CPTA will show a very strong growth in Earnings Per Share. The EPS will grow by 64.41% on average per year.
  • Based on estimates for the next years, CPTA will show a very negative growth in Revenue. The Revenue will decrease by -22.03% on average per year.
EPS Next Y170.69%
EPS Next 2Y138.5%
EPS Next 3Y94.04%
EPS Next 5Y64.41%
Revenue Next Year-34.4%
Revenue Next 2Y-22.29%
Revenue Next 3Y-22.31%
Revenue Next 5Y-22.03%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPTA Yearly Revenue VS EstimatesCPTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CPTA Yearly EPS VS EstimatesCPTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • CPTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 34.35 indicates a quite expensive valuation of CPTA.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, CPTA is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 34.35
CPTA Price Earnings VS Forward Price EarningsCPTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -4.73
CPTA Per share dataCPTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • CPTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CPTA's earnings are expected to grow with 94.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y138.5%
EPS Next 3Y94.04%

More info and screens

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.88%, CPTA is a good candidate for dividend investing.
  • CPTA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 5.88%

5.2 History

  • The dividend of CPTA decreases each year by -32.37%.
  • CPTA has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-32.37%
Div Incr YearsN/A
Div Non Decr YearsN/A
CPTA Yearly Dividends per shareCPTA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2 4 6 8 10

5.3 Sustainability

DPN/A
EPS Next 2Y138.5%
EPS Next 3Y94.04%

More info and screens

Capitala Finance Crp

NASDAQ:CPTA (7/1/2021, 8:00:00 PM)

25.4

+0.85 (+3.46%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.06%
Inst Owner Change0%
Ins Owners17.04%
Ins Owner Change0%
Market Cap68.86M
Revenue(TTM)24.30M
Net Income(TTM)19.35M
Analysts60
Price Target15.3 (-39.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.88%
Yearly Dividend1.49
Dividend Growth(5Y)-32.37%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.35
P/S 2.83
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB N/A
EV/EBITDA -4.73
EPS(TTM)-0.11
EYN/A
EPS(NY)0.74
Fwd EY2.91%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.96
BVpS44.74
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 6.05%
ROE 15.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -2.29%
PM (TTM) 79.62%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.72
Quick Ratio 14.72
Altman-Z 0.08
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.33%
EPS 3Y-73.39%
EPS 5Y-57.96%
EPS Q2Q%125.7%
EPS Next Y170.69%
EPS Next 2Y138.5%
EPS Next 3Y94.04%
EPS Next 5Y64.41%
Revenue 1Y (TTM)-36.77%
Revenue growth 3Y-19.71%
Revenue growth 5Y-16.2%
Sales Q2Q%-30.36%
Revenue Next Year-34.4%
Revenue Next 2Y-22.29%
Revenue Next 3Y-22.31%
Revenue Next 5Y-22.03%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Capitala Finance Crp / CPTA FAQ

What is the fundamental rating for CPTA stock?

ChartMill assigns a fundamental rating of 5 / 10 to CPTA.


What is the valuation status of Capitala Finance Crp (CPTA) stock?

ChartMill assigns a valuation rating of 5 / 10 to Capitala Finance Crp (CPTA). This can be considered as Fairly Valued.


How profitable is Capitala Finance Crp (CPTA) stock?

Capitala Finance Crp (CPTA) has a profitability rating of 5 / 10.


What is the earnings growth outlook for Capitala Finance Crp?

The Earnings per Share (EPS) of Capitala Finance Crp (CPTA) is expected to grow by 170.69% in the next year.